CSF YKL-40 and pTau181 are related to different cerebral morphometric patterns in early AD

Neurobiology of Aging
Juan Domingo GispertJosé Luis Molinuevo

Abstract

Cerebrospinal fluid (CSF) concentrations of YKL-40 that serve as biomarker of neuroinflammation are known to be altered along the clinico-biological continuum of Alzheimer's disease (AD). The specific structural cerebral correlates of CSF YKL-40 were evaluated across the early stages of AD from normal to preclinical to mild dementia. Nonlinear gray matter (GM) volume associations with CSF YKL-40 levels were assessed in a total of 116 subjects, including normal controls and those with preclinical AD as defined by CSF Aβ < 500 pg/mL, mild cognitive impairment (MCI) due to AD, or mild AD dementia. Age-corrected YKL-40 levels were increased in MCIs versus the rest of groups and showed an inverse u-shaped association with p-tau values. A similar nonlinear relationship was found between GM volume and YKL-40 in inferior and lateral temporal regions spreading to the supramarginal gyrus, insula, inferior frontal cortex, and cerebellum in MCI and AD. These findings for YKL-40 remained unchanged after adjusting for p-tau, which was found to be associated with GM volumes in distinct anatomic areas. CSF YKL-40, a biomarker of glial inflammation, is associated with a cerebral structural signature distinct from that related to p-tau neurodege...Continue Reading

References

Jun 22, 2000·NeuroImage·J Ashburner, K J Friston
Jun 16, 2005·NeuroImage·John Ashburner, Karl J Friston
Sep 1, 2007·NeuroImage·John Ashburner
Mar 29, 2008·Acta Neuropathologica·Dietmar Rudolf ThalEstifanos Ghebremedhin
Jun 15, 2010·Journal of Neuroinflammation·Dafna Bonneh-BarkayClayton A Wiley
Nov 3, 2010·Biological Psychiatry·Rebecca Craig-SchapiroDavid M Holtzman
Apr 26, 2011·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Clifford R JackCreighton H Phelps
May 3, 2011·Neurobiology of Aging·Lidia GlodzikMony J de Leon
Dec 17, 2011·NeuroImage·Eric M Reiman, William J Jagust
Jan 4, 2012·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Stephen F CarterAgneta Nordberg
Oct 9, 2012·Journal of Neuropathology and Experimental Neurology·Dafna Bonneh-BarkayStephanie J Bissel
Jan 8, 2013·Biological Psychiatry·Yvette I Sheline, Marcus E Raichle
Apr 9, 2013·Neurobiology of Aging·Christiane MöllerWiesje M van der Flier
May 23, 2014·Lancet Neurology·Bruno DuboisJeffrey L Cummings
Aug 1, 2014·European Journal of Nuclear Medicine and Molecular Imaging·I L Han ChooAgneta Nordberg
Sep 26, 2014·Dementia and Geriatric Cognitive Disorders Extra·Christoffer RosénHenrik Zetterberg
Nov 8, 2014·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Clayton A WileyPatrick M Kochanek
Dec 3, 2014·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·James VarleyPaul Edison
Mar 21, 2015·Lancet Neurology·Michael T HenekaMarkus P Kummer

❮ Previous
Next ❯

Citations

Jul 18, 2016·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Juan Domingo GispertJosé Luis Molinuevo
Mar 7, 2017·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Filippo BaldacciHarald Hampel
Nov 12, 2017·Molecular Neurodegeneration·Franc LlorensInga Zerr
Mar 28, 2018·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Courtney L SutphenUNKNOWN ADNI
Feb 12, 2020·Reviews in the Neurosciences·Valentin DichevVictoria Sarafian
Nov 3, 2016·Current Opinion in Neurology·Luka Kulic, Paul G Unschuld
Feb 6, 2017·Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring·Juan Domingo GispertJosé Luis Molinuevo
Feb 23, 2019·Journal of Neuroinflammation·Kaja NordengenTormod Fladby
May 28, 2020·Frontiers in Aging Neuroscience·Victoria M PakFannie Onen
May 30, 2016·Alzheimer's & Dementia : Translational Research & Clinical Interventions·Linda J Van EldikKelly Bales
Feb 17, 2019·Cellular and Molecular Life Sciences : CMLS·Kunal DhimanVeer Bala Gupta
Aug 24, 2019·Frontiers in Aging Neuroscience·Yuan LiUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
May 17, 2017·Journal of Alzheimer's Disease : JAD·Roser Sala-LlonchAnders Martin Fjell
Sep 16, 2020·Signal Transduction and Targeted Therapy·Ting ZhaoQiang You
Aug 14, 2020·EMBO Molecular Medicine·Michael EwersNicolai Franzmeier
Mar 23, 2018·Journal of Alzheimer's Disease : JAD·José Luis MolinuevoJuan Domingo Gispert
Apr 15, 2020·Experimental & Molecular Medicine·Sun Ah ParkChae Eun Kim
Nov 21, 2020·International Journal of Molecular Sciences·Bin Zhou, Masanori Fukushima
Sep 14, 2020·Neurobiology of Aging·Andrea VergalloUNKNOWN Alzheimer Precision Medicine Initiative (APMI)
Mar 23, 2021·Journal of Alzheimer's Disease : JAD·Jianwei YangJianping Jia
Mar 31, 2021·Alzheimer's Research & Therapy·Cécile TissotUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
May 7, 2021·Neurology·Bruna BellaverEduardo R Zimmer
Jun 15, 2021·Frontiers in Aging Neuroscience·Dongsheng ZhangXiaoling Zhang
Apr 29, 2020·Dementia and Geriatric Cognitive Disorders·Ione O C WoollacottJonathan D Rohrer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Astrocytes & Amyloid

Astrocytes are thought to play a role in amyloid production and have been implicated in neurodegenerative diseases such as Alzheimer’s disease. Here is the latest research on the relationship between astrocytes and amyloid.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Astrocytes & Neurodegeneration

Astrocytes are important for the health and function of the central nervous system. When these cells stop functioning properly, either through gain of function or loss of homeostatic controls, neurodegenerative diseases can occur. Here is the latest research on astrocytes and neurodegeneration.